Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
Background Patients with atrial fibrillation (AF) are selected for oral anticoagulation based on individual patient characteristics. There is little information on how clinical AF burden associates with the risk of ischaemic stroke or systemic embolism (SSE). The aim of this study was to explore the...
Main Authors: | Samuli Jaakkola, Tuomas O. Kiviniemi, Jussi Jaakkola, Jussi-Pekka Pouru, Ilpo Nuotio, Tuija Vasankari, Juha E. K. Hartikainen, K. E. Juhani Airaksinen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2022.2077430 |
Similar Items
-
Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study
by: Arto Relander, et al.
Published: (2021-01-01) -
How to Optimize Cardioversion of Atrial Fibrillation
by: K. E. Juhani Airaksinen
Published: (2022-06-01) -
Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
by: Saga Itäinen‐Strömberg, et al.
Published: (2020-09-01) -
Fibrillatory wave amplitude and thromboembolic risk in non-anticoagulated patients with atrial fibrillation
by: Arto Relander, et al.
Published: (2024-12-01) -
Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Paritosh Prasai, et al.
Published: (2023-02-01)